Text Size

Dr. Andrew Huberman receives 2017 Cogan Award for Research in Vision and Ophthalmology

Andrew Huberman, PhD
Andrew Huberman, PhD

Andrew Huberman, PhD, associate professor of neurobiology and of ophthalmology (Stanford University School of Medicine) and Catalyst for a Cure researcher (Glaucoma Research Foundation) has received the 2017 Cogan Award from the Association for Research in Vision and Ophthalmology.

The Cogan Award for Research in Vision and Ophthalmology is given annually to a researcher younger than 45 who has made important contributions to vision and ophthalmology research and who shows substantial promise.

Dr. Huberman was honored for his work studying the development, function and repair of mammalian visual circuits. His laboratory is currently trying to understand how to regenerate the diseased and injured visual system and is now initiating pre-clinical studies in humans using virtual reality to try to stimulation repair and recovery of retinal cells in glaucoma and other degenerative conditions.

Other honors and awards for Dr. Andrew Huberman have included:

  • Pew Biomedical Scholar, Pew Charitable Trusts (2013-2017)
  • McKnight Scholar, McKnight Endowment Fund (2013-2016)
  • Catalyst for a Cure Investigator, Glaucoma Research Foundation (2012-2018)
  • Helen Hay Whitney Postdoctoral Fellow, HHWF Foundation (2006-2009)

Dr. Humberman's lab is focused on brain function, development and repair with emphasis on regeneration to prevent and cure blindness. The lab also studies the neural circuits that control visual fear and are developing tools to re-map them for treating anxiety disorders. Their primary aim is to understand and develop therapeutic strategies for retinal and optic nerve damage in glaucoma.

For more information, please visit the Huberman Lab Website.

Last reviewed on June 17, 2021

Was this helpful? Yes No